*THE COMBINATION OF ERIBULIN WITH XEALODA IN TRIPLE NEGATIVE BREAST CANCER.
*WHAT REMAINS A QUESTION IS THE ROLE OF INTERFERON AS AN ADJUVANT (OR MAINTENANCE )THERAPY IN TRIPLE NEGATIVE BREAST CANCER
*I COULD SEE HOW THE ANDROGEN RECEPTOR WOULD BE OF IMPORTANCE IN LUMINAL A BREAST CANCER GIVEN ITS RICH HORMONE RECEPTOR PRESENCE (WHEN LOW Ki-67 IS PRESENT)
No comments:
Post a Comment